drugset / Trial / NCT04272502
Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers
Phase 1
Completed
15 enrolled
Chong Kun Dang Pharmaceutical
Seoul National University Bundang Hospital · collab
RandomizedCrossoverOpen-labelTreatment
Summary
Phase I clinical trial to compare the pharmacokinetics and safety of CKD-348 with co-administration of CKD-828, D326 and D337 in healthy adult volunteers
Timeline
- Start
- 2019-06-04
- Primary completion
- 2019-08-26
- Completion
- 2019-08-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CKD-348 | Unknown | — | — |
| Background | CKD-828 | Unknown | — | — |
| Background | D326 | Unknown | — | — |
| Background | D337 | Unknown | — | — |
Indications
No indication recorded.